Publication Name	World Journal of Gastroenterology
Manuscript ID	4948
Country	Spain

Received	2013-08-06 08:33
Peer-Review Started	2013-08-07 15:59
To Make the First Decision	2013-08-21 18:50
Return for Revision	2013-08-27 11:35
Revised	2013-09-20 02:06
Second Decision	2013-10-21 17:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-10-22 07:05
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-11-14 05:49
Typeset the Manuscript	2013-12-16 11:54
Publish the Manuscript Online	2014-01-14 20:11

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Alicia Algaba, Iván Guerra, Ángel Castaño, Gema de la Poza, Víctor M Castellano, Montserrat López and Fernando Bermejo
Funding Agency and Grant Number
Corresponding Author	Alicia Algaba, MSc, Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Camino del Molino, 2, Fuenlabrada, 28942 Madrid, Spain. alicia_algaba@hotmail.com
Key Words	Extra-intestinal cancer; Inflammatory bowel disease; Cancer risk; Background population; Urothelial carcinoma; Appendiceal mucinous cystadenoma; Neuroendocrine carcinoma; Rectal carcinoid
Core Tip	Several studies have reported increased rates of colorectal cancer in patients with inflammatory bowel diseases but limited data are available regarding incidence of extraintestinal malignancies in these patients. The present study demonstrates a higher risk of urinary bladder cancer, mucinous cystadenoma of the appendix and of neuroendocrine tumors, and a low colorectal cancer risk, in patients with inflammatory bowel disease in our environment. We raised the question of whether current cancer screening strategies need to be reviewed and adapted to the characteristics of each patient.
Publish Date	2014-01-14 20:11
Citation	Algaba A, Guerra I, Casta?o á, de la Poza G, Castellano VM, López M, Bermejo F. Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease. World J Gastroenterol 2013; 19(48): 9359-9365
URL	http://www.wjgnet.com/1007-9327/full/v19/i48/9359.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i48.9359

Full Article (PDF)	WJG-19-9359.pdf
Manuscript File	4948-Review.doc
Answering Reviewers	4948-Answering reviewers.pdf
Copyright License Agreement	4948-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	4948-Language certificate.docx
Peer-review Report	4948-Peer reviewer(s).pdf
Scientific Editor Work List	4948-Scientific editor work list.doc